Find clinical trials for Lymphoma in Seattle, WA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Seattle, WA, USA:
a standard 3+3 design. Once the maximum tolerated dose (MTD) is determined amongst patients with relapsed or refractory grade 1-3a follicular lymphoma...
Phase 1, Phase 2
Seattle, Washington, United States and 2 other locations
This is a Phase 1/2 study of imvotamab in adult subjects with relapsed or refractory B-cell Non-Hodgkin Lymphoma. This study will consist of...
Phase 1, Phase 2
Seattle, Washington, United States and 26 other locations
Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...
Phase 3
Seattle, Washington, United States and 125 other locations
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....
Phase 1, Phase 2
Seattle, Washington, United States and 50 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Tacoma, Washington, United States and 50 other locations
This phase II trial studies how well pembrolizumab with rituximab or obinutuzumab work in treating patients with follicular lymphoma or diff...
Phase 2
Seattle, Washington, United States
This phase I/II trial studies the safety of acalabrutinib and axicabtagene ciloleucel in treating patients with B-cell lymphoma. Acalabrutin...
Phase 1, Phase 2
Seattle, Washington, United States
017 works in treating patients with non-Hodgkin's lymphoma whose disease has come back or has not responded to treatment....
Phase 1
Seattle, Washington, United States and 13 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Seattle, Washington, United States and 215 other locations
The purpose of this study is to define the recommended Phase 2 Dose, safety, tolerability, immunogenicity, and preliminary efficacy of EO2463 during...
Phase 1, Phase 2
Seattle, Washington, United States and 9 other locations
Clinical trials
Research sites
Resources
Legal